116 related articles for article (PubMed ID: 35904370)
1. Outstanding MRI contrast with dysprosium phosphate nanoparticles of tuneable size.
Gómez-González E; Caro C; García-Martín ML; Becerro AI; Ocaña M
Nanoscale; 2022 Aug; 14(31):11461-11470. PubMed ID: 35904370
[TBL] [Abstract][Full Text] [Related]
2. Holmium phosphate nanoparticles as negative contrast agents for high-field magnetic resonance imaging: Synthesis, magnetic relaxivity study and in vivo evaluation.
Gómez-González E; Caro C; Martínez-Gutiérrez D; García-Martín ML; Ocaña M; Becerro AI
J Colloid Interface Sci; 2021 Apr; 587():131-140. PubMed ID: 33360885
[TBL] [Abstract][Full Text] [Related]
3. Dysprosium and Holmium Vanadate Nanoprobes as High-Performance Contrast Agents for High-Field Magnetic Resonance and Computed Tomography Imaging.
Gómez-Gónzalez E; Núñez NO; Caro C; García-Martín ML; Fernández-Afonso Y; de la Fuente JM; Balcerzyk M; Ocaña M
Inorg Chem; 2021 Jan; 60(1):152-160. PubMed ID: 33201695
[TBL] [Abstract][Full Text] [Related]
4. Carboxylate functionalized NaDy(MoO
Gómez-González E; Núñez NO; Caro C; Garcia-Martín ML; Ocaña M
J Colloid Interface Sci; 2023 Jan; 629(Pt A):310-321. PubMed ID: 36081210
[TBL] [Abstract][Full Text] [Related]
5. Ultra-small manganese dioxide nanoparticles with high
Jiang Y; Gu H; Cai Z; Fu S; Cao Y; Jiang L; Wu C; Chen W; Xia C; Lui S; Song B; Gong Q; Ai H
Biomater Sci; 2023 Jun; 11(12):4359-4369. PubMed ID: 37144293
[TBL] [Abstract][Full Text] [Related]
6. Magnetic, biocompatible FeCO
Thangudu S; Yu CC; Lee CL; Liao MC; Su CH
J Nanobiotechnology; 2022 Mar; 20(1):157. PubMed ID: 35337331
[TBL] [Abstract][Full Text] [Related]
7. Tuning of the size of Dy2O3 nanoparticles for optimal performance as an MRI contrast agent.
Norek M; Kampert E; Zeitler U; Peters JA
J Am Chem Soc; 2008 Apr; 130(15):5335-40. PubMed ID: 18355014
[TBL] [Abstract][Full Text] [Related]
8. NaDyF4 Nanoparticles as T2 Contrast Agents for Ultrahigh Field Magnetic Resonance Imaging.
Das GK; Johnson NJ; Cramen J; Blasiak B; Latta P; Tomanek B; van Veggel FC
J Phys Chem Lett; 2012 Feb; 3(4):524-9. PubMed ID: 26286058
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous Iron Oxide/Dysprosium Oxide Nanoparticles Target Liver for Precise Magnetic Resonance Imaging of Liver Fibrosis.
Balachandran YL; Wang W; Yang H; Tong H; Wang L; Liu F; Chen H; Zhong K; Liu Y; Jiang X
ACS Nano; 2022 Apr; 16(4):5647-5659. PubMed ID: 35312295
[TBL] [Abstract][Full Text] [Related]
10. One-pot facile synthesis of PEGylated superparamagnetic iron oxide nanoparticles for MRI contrast enhancement.
Dai L; Liu Y; Wang Z; Guo F; Shi D; Zhang B
Mater Sci Eng C Mater Biol Appl; 2014 Aug; 41():161-7. PubMed ID: 24907749
[TBL] [Abstract][Full Text] [Related]
11. One-pot preparation of hydrophilic manganese oxide nanoparticles as T
Li J; Wu C; Hou P; Zhang M; Xu K
Biosens Bioelectron; 2018 Apr; 102():1-8. PubMed ID: 29101783
[TBL] [Abstract][Full Text] [Related]
12. Ultrasmall Europium, Gadolinium, and Dysprosium Oxide Nanoparticles: Polyol Synthesis, Properties, and Biomedical Imaging Applications.
Yue H; Park JY; Chang Y; Lee GH
Mini Rev Med Chem; 2020; 20(17):1767-1780. PubMed ID: 32496986
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticulated Bimodal Contrast Agent for Ultra-High-Field Magnetic Resonance Imaging and Spectral X-ray Computed Tomography.
González-Mancebo D; Becerro AI; Caro C; Gómez-González E; García-Martín ML; Ocaña M
Inorg Chem; 2024 Jun; 63(23):10648-10656. PubMed ID: 38807360
[TBL] [Abstract][Full Text] [Related]
14. Development of Superparamagnetic Nanoparticles Coated with Polyacrylic Acid and Aluminum Hydroxide as an Efficient Contrast Agent for Multimodal Imaging.
González-Gómez MA; Belderbos S; Yañez-Vilar S; Piñeiro Y; Cleeren F; Bormans G; Deroose CM; Gsell W; Himmelreich U; Rivas J
Nanomaterials (Basel); 2019 Nov; 9(11):. PubMed ID: 31731823
[TBL] [Abstract][Full Text] [Related]
15. High relaxivities and strong vascular signal enhancement for NaGdF4 nanoparticles designed for dual MR/optical imaging.
Naccache R; Chevallier P; Lagueux J; Gossuin Y; Laurent S; Vander Elst L; Chilian C; Capobianco JA; Fortin MA
Adv Healthc Mater; 2013 Nov; 2(11):1478-88. PubMed ID: 23666643
[TBL] [Abstract][Full Text] [Related]
16. The feasibility of NaGdF
Zhang W; Zhang S; Gao P; Lan B; Li L; Zhang X; Li L; Lu H
Med Phys; 2020 Feb; 47(2):662-671. PubMed ID: 31742714
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, Characterizations, and 9.4 Tesla T
Marasini S; Yue H; Ho SL; Park JA; Kim S; Jung KH; Cha H; Liu S; Tegafaw T; Ahmad MY; Ghazanfari A; Chae KS; Chang Y; Lee GH
Nanomaterials (Basel); 2021 May; 11(5):. PubMed ID: 34065511
[TBL] [Abstract][Full Text] [Related]
18. Using ferromagnetic nanoparticles with low Curie temperature for magnetic resonance imaging-guided thermoablation.
Herynek V; Turnovcová K; Veverka P; Dědourková T; Žvátora P; Jendelová P; Gálisová A; Kosinová L; Jiráková K; Syková E
Int J Nanomedicine; 2016; 11():3801-11. PubMed ID: 27540292
[TBL] [Abstract][Full Text] [Related]
19. Magnetic PEGylated Pt3Co nanoparticles as a novel MR contrast agent: in vivo MR imaging and long-term toxicity study.
Yin S; Li Z; Cheng L; Wang C; Liu Y; Chen Q; Gong H; Guo L; Li Y; Liu Z
Nanoscale; 2013 Dec; 5(24):12464-73. PubMed ID: 24165858
[TBL] [Abstract][Full Text] [Related]
20. Paramagnetic dysprosium oxide nanoparticles and dysprosium hydroxide nanorods as T₂ MRI contrast agents.
Kattel K; Park JY; Xu W; Kim HG; Lee EJ; Bony BA; Heo WC; Jin S; Baeck JS; Chang Y; Kim TJ; Bae JE; Chae KS; Lee GH
Biomaterials; 2012 Apr; 33(11):3254-61. PubMed ID: 22277624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
